All News

guidelines.recommendations.jpg

New ACR RA Guidelines and Practice Changing Abstracts: RA Panel

d Jonathan Kay, MD

Dr. Jonathan Kay leads an international panel discussion on the new ACR RA guidelines and several practice-changing abstracts presented at the 2020 ACR meeting. Panelists include Dr. Kathryn Dao, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway and Dr. Sheila Reyes.

Read Article
ACR20 Podcast

ACR20 - Autoinflammatory & Still's Disease Panel

d Jack Cush, MD

This podcast features a discussion of autoinflammatory and Still's disease abstracts from virtual ACR 2020. Dr. Jack Cush is joined by a panel of experts including Drs. Olga Petryna, Bella Metha and Michael Ombrello.

Read Article
gene1.jpg

Undifferentiated Autoinflammatory Syndrome Called VEXAS

d Jack Cush, MD

Saturday's session on autoinflammatory syndromes featured Dr. Dan Kastner addressing - The Adult with Undifferentiated Autoinflammatory Disease.

Read Article
Let us know your thoughts on our article titled "Undifferentiated Autoinflammatory Syndrome Called VEXAS" https://t.co/afNK3UuZef #ACR20 https://t.co/fp2sX9w894

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @synovialjoints : Can we find Axial Spa (FaxSpa) using social media? This study used an online screening tool (A-tool) on social media in patients with back pain. 42% had a positive screen and referred for review @RheumNow #ACR20 Abstr#1894

Dr. John Cush RheumNow ( View Tweet)

Dr. Kathryn Dao ( @KDAO2011) reviews abstract #0533 presented at #ACR20 on male osteoporosis. https://t.co/Z0NLcJzslV https://t.co/SSoIA7Eetg

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @DrMiniDey : Late breaking: in older #rheumatoidarthritis patients, those taking MTX have 2x risk of #VTE compared to those on HCQ. Important to consider #thromboembolic risk factors when starting new RA treatment. Abs#2000 #ACR20 https://t.co/lMYlXgaHyE https://t.co/0Fdone9yb3

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @drdavidliew : Mavrilimumab (anti-GM-CSF) in GCA, phase 2 GM-CSF upstream to both Th1 & Th17 pathways; potential for dx-modifying?? PNL induction then enrol+PNL taper GCA flare (ESR/CRP+Sx/imaging): mavrilimumab RRR 62% ABSTL06 https://t.co/xxjd2lTSUe https://t.co/uuBOnbk6Ab

Links:

Dr. John Cush RheumNow ( View Tweet)
Did you know we have podcast? Search Rheum Now on Apple/Android or listen directly through the link below. https://t.co/wjBWCrKL34 https://t.co/yhZ2wyujA0

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @synovialjoints : The majority of patients with axSpA were able to use an axSpA smartphone app. recording BASDAI, BASFI 2 weekly. Current disease activity influence adherence to reporting @RheumNow #ACR20 Abstr#1890

Dr. John Cush RheumNow ( View Tweet)

#BestACR20Tweets RT @ejdein1:Abst#2001: Heme changes on MTX? CIRT trial (non-rheumatic pts): Low-dose MTX (15-20mg/w): 2 line cytopenia uncommon (4%), pancytopenia rare (0.5%), Hb decrease 0.4 g/dL but WBC, plt unchanged. Reassuring large pop study shows tolerance of MTX #ACR20

Dr. John Cush RheumNow ( View Tweet)

New podcast up! On this episode titled #ACR20 Epilogue, we review more ACR 2020 abstracts and present a new plan to learn or take in ACR20 content. Listen via the link below or download on Apple/Android podcasts. https://t.co/yj1WIcMtfb https://t.co/YjdYpPZNIC

Links:

Dr. John Cush RheumNow ( View Tweet)
Video:COVID and Rheumatic Disease Patients with Dr. Kevin Winthrop #ACR20 https://t.co/VHIibPNDXG https://t.co/0OVIXzX6su

Links:

Dr. John Cush RheumNow ( View Tweet)
What’s New in Knee Osteoarthritis that Matters? by Dr. Janet Pope ( @Janetbirdope) https://t.co/Ue3o8xAytV https://t.co/YaNftmH9ZN

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @synovialjoints : About half (51%) of patients from the FORWARD registry in the US had at least one telehealth appointment during COVID-19 pandemic and most were satisfied with the appointment @RheumNow #ACR20 Abstr#1962 https://t.co/PEiucSItZq https://t.co/6vzIlQWjOP

Links:

Dr. John Cush RheumNow ( View Tweet)
Watch this three minute video on Subclinical Synovitis with Dr Eric Dein ( @ejdein1) #ACR20 https://t.co/rGqgseyWBv https://t.co/6snzAjbuaU

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Alexa Meara ( @lexmeara) interviews Dr. Cassie Calabrese about iRAE as well as Checkpoint Inhibitor Inflammatory Arthritis and PMR at #ACR20 annual meeting. https://t.co/0qxB6pqb3i https://t.co/W0FZO4W6q6

Links:

Dr. John Cush RheumNow ( View Tweet)
Swollen Joints Associated with Ultrasound Synovitis in PsA by Dr. Robert Chao (@ @doctorRBC) #ACR20 https://t.co/cRBuzrfEpt https://t.co/sgoqsmEyCJ

Links:

Dr. John Cush RheumNow ( View Tweet)
Video report from GCAN: Gout, Urate and the repositioning of innate immunity. NYU's Dr. Michael Pillinger promises deeper looks at #ACR20 activity regarding gout, but starts out reporting data from GCAN. https://t.co/PBglAlK4Dg https://t.co/OrPnCPHylD

Links:

Dr. John Cush RheumNow ( View Tweet)
#BestACR20Tweets RT @ejdein1 :Abst#2001: Heme changes on MTX? CIRT trial (non-rheumatic pts): Low-dose MTX (15-20mg/w):2 line cytopenia uncommon (4%), pancytopenia rare (0.5%), Hb decrease 0.4 g/dL but WBC, plt unchanged. Reassuring large pop study shows tolerance of MTX #ACR20

Dr. John Cush RheumNow ( View Tweet)

×